Cargando…
The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy
Background: Levetiracetam (LEV) is approved for treating epilepsy. The current evidence shows that LEV can cause behavioral problems such as depression. It is well-known that depression is associated with oxidative stress. Therefore, we conducted this study to assess the influence of LEV on depressi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tehran University of Medical Sciences
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189196/ https://www.ncbi.nlm.nih.gov/pubmed/38011345 http://dx.doi.org/10.18502/cjn.v21i4.11719 |